Outsourcing in Clinical Trials South East

15-16 March 2016

Outsourcing in Clinical Trials South East is returning to Cary, North Carolina, in March 2016 for the fifth year running.

Over the last 20 years, there has been a rise in contract research organisations (CROs) as benefits relating to finances and efficiency of outsourcing clinical trials have become widely apparent.

The 2016 event will bring together clinical-stage biotechs with local and nationwide CROs and service providers to address outsourcing challenges throughout the whole process.

High calibre speakers of CEO and founder levels from small-medium companies will attend to discuss real and key industry topics, including new techniques and how to select the right CRO.

This is a two-day event, opening with a panel discussion hosted by field experts to debate and answer all outsourcing queries.

The second day will provide the opportunity to join speaker hosted roundtable sessions and will offer a unique chance for a more focused and interactive way to solve industry challenges.

Key speakers:

  • Envigen Pharmaceuticals CEO Anil Sharma
  • Scioderm president Robert Ryan
  • Micell Technologies Clinical Affairs senior director Charlene Knape
  • VDDI Pharmaceuticals president Stephen Porter
  • Innovate Biopharmaceuticals president Jay P Madan

Contact Details

Outsourcing in Clinical Trials South East
Contact: Kathryn Essery
+44 207 936 6486
Kathryn.Essery@arena-international.com
www.arena-international.com/oct-southeast